Antiphospholipid Antibody–Associated Young Stroke
Word Count : 2800
Objectives to cover:
Introduction: Overview of stroke in young adults and the role of antiphospholipid antibodies as a rare but significant cause.
Epidemiology: Prevalence of antiphospholipid syndrome (APS) among young stroke patients.
Pathophysiology: Mechanism of hypercoagulability leading to arterial thrombosis in APS.
Risk Factors: Contributing factors such as autoimmune disorders, smoking, and hormonal therapy.
Clinical Presentation: Typical neurological deficits and patterns of stroke in APS.
Diagnostic Evaluation: Role of imaging and laboratory tests including lupus anticoagulant and anticardiolipin antibodies.
Management: Acute stroke treatment and long-term anticoagulation strategies.
Prognosis and Complications: Risk of recurrence and long-term neurological outcomes.
Conclusion: Importance of early recognition and targeted therapy to prevent recurrent strokes.